- Home
- ONCO vs YCBD Comparison
ONCO vs YCBD Comparison
Compare ONCO & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- YCBD
- Stock Information
- Founded
- ONCO 2018
- YCBD 2015
- Country
- ONCO United States
- YCBD United States
- Employees
- ONCO N/A
- YCBD N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- ONCO Health Care
- YCBD Health Care
- Exchange
- ONCO Nasdaq
- YCBD Nasdaq
- Market Cap
- ONCO 4.3M
- YCBD 4.5M
- IPO Year
- ONCO 2022
- YCBD N/A
- Fundamental
- Price
- ONCO $2.21
- YCBD $0.51
- Analyst Decision
- ONCO
- YCBD Strong Buy
- Analyst Count
- ONCO 0
- YCBD 1
- Target Price
- ONCO N/A
- YCBD $2.00
- AVG Volume (30 Days)
- ONCO 28.9K
- YCBD 161.6K
- Earning Date
- ONCO 11-13-2025
- YCBD 12-17-2025
- Dividend Yield
- ONCO N/A
- YCBD N/A
- EPS Growth
- ONCO N/A
- YCBD N/A
- EPS
- ONCO N/A
- YCBD N/A
- Revenue
- ONCO $1,223,751.00
- YCBD $19,026,064.00
- Revenue This Year
- ONCO N/A
- YCBD $0.37
- Revenue Next Year
- ONCO N/A
- YCBD $4.95
- P/E Ratio
- ONCO N/A
- YCBD N/A
- Revenue Growth
- ONCO N/A
- YCBD N/A
- 52 Week Low
- ONCO $2.10
- YCBD $0.47
- 52 Week High
- ONCO $179.35
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- ONCO 33.70
- YCBD 26.84
- Support Level
- ONCO $2.17
- YCBD $0.48
- Resistance Level
- ONCO $2.53
- YCBD $0.83
- Average True Range (ATR)
- ONCO 0.20
- YCBD 0.07
- MACD
- ONCO -0.05
- YCBD -0.02
- Stochastic Oscillator
- ONCO 16.01
- YCBD 9.59
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.